AstraZeneca Pharmaceuticals LP
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of[...]
Regeneron Pharmaceuticals Inc.
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in[...]
05/15/2024 | Press release | Distributed by Public on 05/15/2024 06:08
Please select the service you want to use:
Smartlinks | JBS SA | Company News | Top Company News | Investment Funds | Manufacturing | Food Industry | Securities Issuers | Meat Processing and Preserving Companies | Frankfurt Stock Exchange | Sao Paulo Stock Exchange (B3) | Berlin Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Bolsa Mexicana de Valores (BMV) | OTC Markets | Bolsa Institucional de Valores (BIVA)
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact